Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas.

Expert Opin Pharmacother 2018 04 22;19(6):561-575. Epub 2018 Mar 22.

a Division of Dermatology , Baylor Scott and White , Dallas , TX , USA.

Introduction: Despite great therapeutic advancements in psoriasis, four notable difficult-to-treat areas including the scalp, nails, intertriginous (including genitals), and palmoplantar regions, pose a challenge to both physicians and patients. Localized disease of these specific body regions inflicts a significant burden on patients' quality of life and requires an adequate selection of treatments.

Areas Covered: This manuscript discusses appropriate therapies and important treatment considerations for these difficult-to-treat areas based on the available clinical data from the literature.

Expert Opinion: Clinical trials assessing therapies for the difficult-to-treat areas have been inadequate. With the first biological clinical trial for genital psoriasis pending publication, it is with hope that other biological agents will be evaluated for region-specific psoriasis. A greater understanding of the genetic and immunologic aspects of regional psoriasis, as well as identification of unique biomarkers, will further guide management decisions. For example, the recent discovery of the IL-36 receptor gene for generalized pustular psoriasis may prove valuable for other forms of psoriasis. Ultimately, identification of the most beneficial treatments for each psoriasis subtype and difficult-to-treat area will provide patients with maximal quality of life.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1448788DOI Listing
April 2018
39 Reads

Publication Analysis

Top Keywords

difficult-to-treat areas
16
psoriasis
8
quality life
8
difficult-to-treat
5
il-36 receptor
4
clinical data
4
data literatureexpert
4
based clinical
4
receptor gene
4
areas based
4
literatureexpert opinion
4
discovery il-36
4
assessing therapies
4
therapies difficult-to-treat
4
trials assessing
4
clinical trials
4
considerations difficult-to-treat
4
opinion clinical
4
gene generalized
4
psoriasis prove
4

References

(Supplied by CrossRef)

Crowley J et al.
J Drugs Dermatol 2010

Williams AC et al.
Crit Rev Ther Drug Carrier Syst 1992

Similar Publications